Michael Lobban

PFD Report Historic (No Identified Response) Ref: 2019-0489
Date of Report 4 October 2019
Coroner Russell Caller
Response Deadline est. 29 November 2019
Coroner's Concerns (AI summary)
Boots' controlled drug audit and investigation processes for methadone disparities were inadequate, and the General Pharmaceutical Council lacks sufficient reporting requirements, investigative powers, and sanctions for such discrepancies.
View full coroner's concerns
_ investigation carried out by The Boots Company PLC into the disparity of Methadone tablets on this occasion was slow and efforts to contact patients who were_regular prescription users of methadone was not fully followed through_ 5mg body Drug Drug Drug regular Smg during The The

The audit checking of controlled drugs by The Boots Company PLC is not robust in that there is no double check in place in relation to the audit checking procedure followed by Boots. There appears to be no physical check of the contents of prescription boxes when carrying out the audit of schedule 2 controlled drugs The General Pharmaceutical Council The Council") being the Regulator of Pharmaceutical industry in England and Wales does not have any reporting requirements for pharmacies when discovering a discrepancy in schedule 2 controlled drugs. Moreover there appear to be no investigative powers by The Council where it discovers a disparity of these controlled drugs and as a consequence there are no sanctions in circumstances where pharmacies have mislaid drugs during the course of their handling of controlled drugs
Sent To
  • Boots UK Limted
  • GPC
  • NHS England
Response Status
Linked responses 0 of 3
56-Day Deadline 29 Nov 2019
About PFD responses

Organisations named in PFD reports must respond within 56 days explaining what actions they are taking.

Source: Courts and Tribunals Judiciary

Report Sections
Investigation and Inquest
On Tuesday 1Oth September 2019 Russell Caller , Assistant Coronerheard the inquest of Michael Lobban who was found dead at his home on Monday 23rd October 2017 Medical Cause of Death (a) Mixed Consumption when and where and in what circumstances the deceased came by his death: Michael Lobban was on a prescription of Smg Methadone tablets and was required to pick up his prescription form Boots, Queensway London Branch on & regular basis_ Michael Lobban was known to the staff at this Boots branch: On Thursday 1gh October 2017 Michael Lobban picked up 68 x Smg Methadone tablets in accordance with his prescription_The following_Thursday 26th October 2017 during_a Controlled Drug_ Thane Drugs Drug How;

Running Balance audit check by Boots, Queensway Branch there was a disparity in the numbers of Methadone tablets. It transpires there were 51x Smg methadone tablets missing: On the Monday prior to this audit check on Monday 23rd October 2017 days before Boots discovered the disparity of 51 of methadone tablets) Michael Lobban was found dead in his home at 31c Talbot Road London W2 5JG with; inter alia, an excessive amount of methadone in his blood 0.56 uglml in his blood) which amounts to significant overdose of methadone. There were other drugs found in Michael Lobban's in the toxicology report taken after death. Conclusion as to the death: Related
Circumstances of the Death
For many years Michael Lobban had been suffering from serious mental health issues and had been under the and Alcohol Well-being Service (DAWS) for a number of years . He suffered from dependency and mental illness and had periods of overdosing causing self-harm and there had been threats of suicide_ Michael Lobban was on a prescription of Smg Methadone tablets and was required to pick up his prescription form Boots, Queensway London Branch on a basis. Michael Lobban was known to the staff at this Boots branch: On Thursday 1gih October 2017 Michael Lobban picked up 68 X Methadone tablets in accordance with his prescription: On the following Thursday 26h October 2017 a Controlled Drug Running Balance audit check by Boots, Queensway Branch there was a disparity in the numbers of Methadone tablets. It transpires there were 51x Smg methadone tablets missing: On the Monday prior to the audit check on Monday 23rd October 2017 3 days before Boots discovered the disparity of 51 x 5 mg of methadone tablets) Michael Lobban was found dead in his home with, inter alia, an excessive amount of methadone in his blood 0.56 ug/ml in his blood) which amounts to a significant overdose of methadone There were other drugs found in Michael Lobban's body in the toxicology report taken after death.
Action Should Be Taken
In my opinion action should be taken to prevent future deaths and believe you ANDIOR your organisation have the power to take such action. It is for each addressee to respond t0 matters relevant to them. The Council should implement industry wide policies and reporting requirements by pharmaceutical companies in relation to Drug Discrepancy for all Controlled drugs and
2.The Boots Company PLC should review its processes and procedures in dealing with occurrences f drug disparity for controlled drugs which should include: A): make robust rules to ensure contact with a patient or third party that could be affected by a disparity of controlled drugs_ B) ensure the physical checking of the contents of prescription boxes for controlled drugs is robust and secure C) to implement a second check in relation to the controlled drug register for Controlled drugs_
Related Inquiry Recommendations

Public inquiry recommendations addressing similar themes

Drug Prescription Documentation
Hyponatraemia Inquiry
Poor prescription security

Data sourced from Courts and Tribunals Judiciary under the Open Government Licence.